Torrent Pharmaceuticals Limited has informed the Exchange about General Updates
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) dated 24th September 2025, alleging that the company overcharged for two drugs during the period May 2018 to July 2020 and for one month in August 2023. The notice, issued under the Drug Price Control Order 2013 (DPCO), imposes a penalty of ₹60,28,721 (around ₹60.29 lakhs). The company received the notice on 29th September 2025 and has assessed that there is no material impact on its financials, operations, or other activities from this demand.
The penalty amount is small relative to Torrent Pharma's overall size and the company has stated there is no material financial or operational impact, so this is unlikely to move the stock meaningfully. However, it reflects ongoing regulatory scrutiny on drug pricing in the pharma sector.